New restrictions on how insurers can sell private health and prescription drug plans for people covered by Medicare are set to take effect Oct. 1, federal officials have announced. The regulations, meant to deter deceptive and aggressive marketing tactics, prohibit telemarketing, door-to-door sales and other unsolicited sales pitches.